Logo

UroGenesys, Protein Pathways Form Alliance for Cancer Genomics and Proteomics

Mar 10, 2000
Premium

S

ANTA MONICA, Calif.--UroGenesys and Protein Pathways have formed an alliance to apply Protein Pathways’ bioinformatics technologies to UroGenesys’ database of cancer-associated antigens. The companies expect the combination of their genomics and proteomics expertise to uncover functional information that will guide therapeutic development of UroGenesys’ antigens, as well as identify new product candidates for cancer therapy. Financial terms of the collaboration were not disclosed.

Filed under

Informatics
Breaking News
The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.